PharmTech News

Mar 29, 2018
By Pharmaceutical Technology Editors
EMA has recommended approval of the biosimilar for the same indications as Roche’s Herceptin (trastuzumab).
Mar 29, 2018
By Pharmaceutical Technology Editors
Novartis’ Sandoz is seeking approval of its biosimilar referencing Johnson & Johnson’s Remicade (infliximab) for all of Remicade’s indications across gastroenterology, rheumatology, and dermatology.
Mar 29, 2018
By Pharmaceutical Technology Editors
The companies will co-develop and co-promote a CAR-T cell therapy in the United States.
Mar 29, 2018
By Pharmaceutical Technology Editors
The acquisition strengthens Celgene’s position in the global cellular immunotherapy space.
Mar 29, 2018
Congress passed a $1.3-trillion omnibus budget bill March 22, 2018 that increases federal support for biomedical research and health programs for fiscal year 2018.
Mar 28, 2018
By Pharmaceutical Technology Editors
Takeda is considering approaching Shire with a possible offer.
Mar 28, 2018
By Pharmaceutical Technology Editors
The company has developed an intelligent laminate for supply chain security and traceability in addition to a new business unit that develops intelligent hyperspectral imaging solutions.
Mar 27, 2018
By Pharmaceutical Technology Editors
MedPharm has received a multi-million dollar investment by Ampersand Capital Partners to diversify its service offering and regional coverage.
Mar 27, 2018
By Pharmaceutical Technology Editors
Cleanroom floor and wall solutions from Sika meet rigorous standards for pharmaceutical manufacturing facilities.
Mar 27, 2018
By Pharmaceutical Technology Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
native1_300x100
lorem ipsum